Lung cancer is a common malignant tumor in China, and surgery is one of the important methods. However, postoperative adjuvance** is important for reducing the risk of lung cancer**. So, what conditions do lung cancer patients need postoperative assistance**?This article will elaborate on this issue.
1. Staging of lung cancer
First of all, the stage of lung cancer is an important basis for deciding whether postoperative adjuvant is needed**. In general, lung cancer can be classified into stage I, stage II, stage III, and stage IV. Among them, stage A lung cancer does not require postoperative adjuvant **, and only needs to maintain regular follow-up and re-examination after tumor resectionPatients with high-risk stage B, high-risk stage A, and above stage B lung cancer all require postoperative adjuvants**.
2. Grade of the tumor
Tumor grade is an important indicator to measure the degree of malignancy of tumor. According to the morphology, nuclear image and other characteristics of tumor cells, tumors can be divided into low-grade malignancy, moderate malignancy and high malignancy. In general, patients with low- and moderate-grade malignant lung cancer can be left without adjuvant after surgery**, but patients with high-grade malignant lung cancer may require postoperative adjuvance**.
3. The size and extent of the tumor
The size and extent of the tumour are also a factor in determining the need for postoperative adjuvant**. The larger the tumor, the more likely it is to metastasize, so postoperative adjuvance is required to reduce the risk. Similarly, the wider the extent of tumor invasion, the higher the risk, so postoperative adjuvant is also required.
4. Patient's age and physical condition
The patient's age and physical condition are also factors in deciding whether postoperative assistance is needed**. In general, young, well-being lung cancer patients can choose adjuvant after surgery to reduce the risk. However, for older or medically ill lung cancer patients, postoperative adjuvance** may not be the best option and needs to be decided on a case-by-case basis and on the doctor's advice.
5. Tumor cell type
Tumor cell type is also a factor in determining the need for postoperative adjuvant**. Patients with non-small cell lung cancer (NSCLC) often require adjunct** after surgery to reduce their risk. However, the effect of adjuvant adjuvant ** after surgery for patients with small cell lung cancer (SCLC) is unclear and needs to be decided based on the patient's specific situation and the doctor's recommendation.
Cancer In conclusion, postoperative adjuvance** is important for reducing the risk of lung cancer**. However, the decision to administer postoperative assistance** depends on the patient's specific situation and the doctor's recommendation. For patients who need postoperative assistance**, it is important to actively cooperate with the doctor and follow the doctor's advice** to minimize the risk of lung cancer**.